Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philipp Ehlermann

Showing results (21-30 of 82) with videos related to

Pageof 9
Sort By:
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|June 24, 2020
Five-year results of heart rate control with ivabradine or metoprolol succinate in patients after heart transplantationRasmus Rivinius, Matthias Helmschrott, Ann-Kathrin Rahm, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|June 4, 2020
The diagnostic benefit of 16S rDNA PCR examination of infective endocarditis heart valves: a cohort study of 146 surgical cases confirmed by histopathologyChristina Armstrong, Tim Christian Kuhn, Matthias Dufner, et al.
ESC Heart Failure|July 2, 2021
Newly acquired complete right bundle branch block early after heart transplantation is associated with lower survivalAnn-Kathrin Rahm, Matthias Helmschrott, Fabrice F Darche, et al.
BMC Medical Genetics|October 30, 2008
Adverse events in families with hypertrophic or dilated cardiomyopathy and mutations in the MYBPC3 genePhilipp Ehlermann, Dieter Weichenhan, Jörg Zehelein, et al.
Clinical Epidemiology|October 13, 2018
COPD in patients after heart transplantation is associated with a prolonged hospital stay, early posttransplant atrial fibrillation, and impaired posttransplant survivalRasmus Rivinius, Matthias Helmschrott, Arjang Ruhparwar, et al.
ESC Heart Failure|March 21, 2020
Elevated pre-transplant pulmonary vascular resistance is associated with early post-transplant atrial fibrillation and mortalityRasmus Rivinius, Matthias Helmschrott, Arjang Ruhparwar, et al.
Drug Design, Development and Therapy|November 16, 2013
Heart rate reduction for 36 months with ivabradine reduces left ventricular mass in cardiac allograft recipients: a long-term follow-up studyAndreas O Doesch, Susanne Mueller, Christian Erbel, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|July 23, 2011
Is there an additional benefit of serial NT-proBNP measurements in patients with stable chronic heart failure receiving individually optimized therapy?Jennifer Franke, Lutz Frankenstein, Dieter Schellberg, et al.
ESC Heart Failure|July 2, 2020
Combined amiodarone and digitalis therapy before heart transplantation is associated with increased post-transplant mortalityRasmus Rivinius, Matthias Helmschrott, Ann-Kathrin Rahm, et al.
Drug Design, Development and Therapy|December 19, 2013
Conversion to generic cyclosporine A in stable chronic patients after heart transplantationMaximilian Kraeuter, Matthias Helmschrott, Christian Erbel, et al.
Pageof 9

Showing results (21-30 of 82) with videos related to

Sort By:
Pageof 9
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|June 24, 2020
Five-year results of heart rate control with ivabradine or metoprolol succinate in patients after heart transplantationRasmus Rivinius, Matthias Helmschrott, Ann-Kathrin Rahm, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|June 4, 2020
The diagnostic benefit of 16S rDNA PCR examination of infective endocarditis heart valves: a cohort study of 146 surgical cases confirmed by histopathologyChristina Armstrong, Tim Christian Kuhn, Matthias Dufner, et al.
ESC Heart Failure|July 2, 2021
Newly acquired complete right bundle branch block early after heart transplantation is associated with lower survivalAnn-Kathrin Rahm, Matthias Helmschrott, Fabrice F Darche, et al.
BMC Medical Genetics|October 30, 2008
Adverse events in families with hypertrophic or dilated cardiomyopathy and mutations in the MYBPC3 genePhilipp Ehlermann, Dieter Weichenhan, Jörg Zehelein, et al.
Clinical Epidemiology|October 13, 2018
COPD in patients after heart transplantation is associated with a prolonged hospital stay, early posttransplant atrial fibrillation, and impaired posttransplant survivalRasmus Rivinius, Matthias Helmschrott, Arjang Ruhparwar, et al.
ESC Heart Failure|March 21, 2020
Elevated pre-transplant pulmonary vascular resistance is associated with early post-transplant atrial fibrillation and mortalityRasmus Rivinius, Matthias Helmschrott, Arjang Ruhparwar, et al.
Drug Design, Development and Therapy|November 16, 2013
Heart rate reduction for 36 months with ivabradine reduces left ventricular mass in cardiac allograft recipients: a long-term follow-up studyAndreas O Doesch, Susanne Mueller, Christian Erbel, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|July 23, 2011
Is there an additional benefit of serial NT-proBNP measurements in patients with stable chronic heart failure receiving individually optimized therapy?Jennifer Franke, Lutz Frankenstein, Dieter Schellberg, et al.
ESC Heart Failure|July 2, 2020
Combined amiodarone and digitalis therapy before heart transplantation is associated with increased post-transplant mortalityRasmus Rivinius, Matthias Helmschrott, Ann-Kathrin Rahm, et al.
Drug Design, Development and Therapy|December 19, 2013
Conversion to generic cyclosporine A in stable chronic patients after heart transplantationMaximilian Kraeuter, Matthias Helmschrott, Christian Erbel, et al.
Pageof 9